Scott Metcalfe
Scott Metcalfe publishes mostly in Economics and Econometrics, Endocrinology, Diabetes and Metabolism and Oncology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Lipoproteins and Cardiovascular Health.
- World rank
- #4,410,312 of 7,710,434 ranked researchers
- Rank in New Zealand
- #15,236 of 21,128
- Works
- 78
- Citations
- 654
- Citations per work
- 8.4
What does Scott Metcalfe research?
Scott Metcalfe's work is mostly in Medicine (20%), Economics, Econometrics and Finance (18%), Health Professions (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4659.0%
- Health Sciences1823.3%
- Medicine1619.9%
- Health Professions33.4%
- Social Sciences1417.7%
- 1Economics and Econometrics18% of their works
- 2Endocrinology, Diabetes and Metabolism7% of their works
- 3Oncology5% of their works
- 4Surgery4% of their works
- 5General Health Professions3% of their works
- 6Public Health, Environmental and Occupational Health3% of their works
Research topics
Which keywords describe Scott Metcalfe's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Clinical Trials, Pharmaceutical Industry, Infectious Diseases, Public Health, Drug Development Costs and Generic Drugs.
- Type 2 Diabetes
- Pediatric Pharmacokinetics
- Conflict of Interest
- Human Health
- Antimicrobial Stewardship
- Statins
- Generic Drugs
- Public Health
- Pharmaceutical Industry
- Quality of Life
- Cost-effectiveness Analysis
- Clinical Trials
- Infectious Diseases
- Drug Development Costs
- Cholesterol-lowering
- Antibiotic Resistance
- Climate Change
- Cardiovascular Outcomes
- Off-Label Drug Use
- Research Outcome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cost-effectiveness Analysis181 topic
- Quality of Life181 topic
- Clinical Trials143 topics
- Pharmaceutical Industry112 topics
- Infectious Diseases102 topics
- Public Health102 topics
- Drug Development Costs71 topic
- Generic Drugs71 topic
- Cholesterol-lowering61 topic
- Statins61 topic
- Antibiotic Resistance51 topic
- Antimicrobial Stewardship51 topic
- Climate Change51 topic
- Human Health51 topic
- Cardiovascular Outcomes41 topic
- Conflict of Interest41 topic
- Off-Label Drug Use41 topic
- Pediatric Pharmacokinetics41 topic
- Research Outcome41 topic
- Type 2 Diabetes41 topic
Where does Scott Metcalfe work?
Scott Metcalfe's main affiliation in the publication record is Pharmac, New Zealand.
How many publications and citations does Scott Metcalfe have?
OpenAlex counts 78 works and 654 citations for Scott Metcalfe, an h-index of 14, ranking #4,410,312 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Scott Metcalfe. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.